Table 2.
Exposure rate (%) of drugs most prescribed of neonates admitted to NICUs in Brazil
GA < 28 weeks | GA 28–30 weeks | GA 31–33 weeks | GA 34–36 weeks | GA ≥ 37 weeks | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | ER | n | ER | n | ER | n | ER | n | ER | |||||
aminophylline | 22 | 3.99 | aminophylline | 29 | 3.52 | aminophylline | 36 | 5.10 | gentamicin | 28 | 3.97 | fentanyl | 23 | 2.77 |
phytomenadione | 19 | 3.44 | phytomenadione | 28 | 3.40 | ampicillin | 27 | 3.82 | ampicillin | 26 | 3.69 | heparin | 23 | 2.77 |
multivitamins without mineralsa | 18 | 3.26 | multivitamins without mineralsa | 27 | 3.28 | gentamicin | 27 | 3.82 | fentanyl | 21 | 2.98 | gentamicin | 18 | 2.17 |
folinic acid | 17 | 3.08 | heparin | 25 | 3.03 | dobutamine | 19 | 2.69 | multivitamins without mineralsa | 20 | 2.84 | ampicillin | 17 | 2.05 |
ampicillin | 16 | 2.90 | folinic acid | 24 | 2.91 | phytomenadione | 19 | 2.69 | phytomenadione | 19 | 2.70 | metamizole | 15 | 1.81 |
gentamicin | 16 | 2.90 | ampicillin | 22 | 2.67 | multivitaminsb | 18 | 2.55 | folinic acid | 18 | 2.55 | dobutamine | 15 | 1.81 |
fentanyl | 15 | 2.72 | gentamicin | 21 | 2.55 | multivitamins without mineralsa | 17 | 2.41 | heparin | 18 | 2.55 | ranitidine | 15 | 1.81 |
heparin | 15 | 2.72 | fentanyl | 19 | 2.31 | heparin | 16 | 2.27 | ranitidine | 18 | 2.55 | vancomycin | 12 | 1.45 |
pulmonary surfactant | 11 | 1.99 | pulmonary surfactant | 19 | 2.31 | folinic acid | 15 | 2.12 | dobutamine | 14 | 1.99 | domperidone | 11 | 1.33 |
meropenem | 10 | 1.81 | dobutamine | 18 | 2.18 | vancomycin | 15 | 2.12 | domperidone | 13 | 1.84 | alprostadil | 10 | 1.20 |
vancomycin | 10 | 1.81 | domperidone | 18 | 2.18 | fentanyl | 14 | 1.98 | metamizole | 12 | 1.70 | phenobarbital | 10 | 1.20 |
dobutamine | 9 | 1.63 | vancomycin | 16 | 1.94 | domperidone | 11 | 1.56 | multivitaminsb | 11 | 1.56 | phytomenadione | 10 | 1.20 |
amphotericin B | 6 | 1.09 | meropenem | 14 | 1.70 | amikacin | 10 | 1.42 | pulmonary surfactant | 9 | 1.28 | folinic acid | 9 | 1.08 |
cefepime | 6 | 1.09 | multivitaminsb | 13 | 1.58 | pulmonary surfactant | 10 | 1.42 | epinephrine | 8 | 1.13 | amikacin | 9 | 1.08 |
domperidone | 6 | 1.09 | amikacin | 8 | 0.97 | ranitidine | 8 | 1.13 | furosemide | 8 | 1.13 | midazolam | 9 | 1.08 |
teicoplanin | 6 | 1.09 | amphotericin B | 8 | 0.97 | cefepime | 7 | 0.99 | vancomycin | 8 | 1.13 | multivitamins without mineralsa | 9 | 1.08 |
epinephrine | 5 | 0.91 | cefepime | 8 | 0.97 | metamizole | 6 | 0.85 | aminophylline | 7 | 0.99 | furosemide | 8 | 0.96 |
tricalcium phosphate | 5 | 0.91 | epinephrine | 8 | 0.97 | hydrocortisone | 6 | 0.85 | cefepime | 7 | 0.99 | epinephrine | 6 | 0.72 |
multivitaminsb | 5 | 0.91 | omeprazole | 8 | 0.97 | omeprazole | 6 | 0.85 | omeprazole | 7 | 0.99 | meropenem | 6 | 0.72 |
ranitidine | 5 | 0.91 | tricalcium phosphate | 7 | 0.85 | epinephrine | 5 | 0.71 | amikacin | 6 | 0.85 | multivitaminsb | 6 | 0.72 |
ferrous sulfate | 5 | 0.91 | ranitidine | 7 | 0.85 | tricalcium phosphate | 5 | 0.71 | mineral oil | 6 | 0.85 | dexamethasone | 5 | 0.68 |
ER exposure rate per 100 neonates
avitamins A, B2, B3, B5, B6, C, D, E
bvitamins A, B1, B2, B3, B5, B6, B8, C, D2, E